These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4473995)

  • 1. The population of cells in paroxysmal nocturnal haemoglobinuria of intermediate sensitivity to complement lysis: significance and mechanism of increased immune lysis.
    Rosse WF; Adams JP; Thorpe AM
    Br J Haematol; 1974 Oct; 28(2):181-90. PubMed ID: 4473995
    [No Abstract]   [Full Text] [Related]  

  • 2. Paroxysmal nocturnal haemoglobinuria: an easily missed entity.
    Mohamed M; Koay J
    Med J Aust; 2021 Sep; 215(6):254-256.e1. PubMed ID: 34458985
    [No Abstract]   [Full Text] [Related]  

  • 3. Immune hemolysis and a basic peptide from cobra venom.
    Okada H; Campbell W
    J Immunol; 1974 Nov; 113(5):1647-9. PubMed ID: 4472944
    [No Abstract]   [Full Text] [Related]  

  • 4. The lysis of paroxysmal nocturnal haemoglobinuria red cells by serum and cobra factor.
    Kabakçi T; Rosse WF; Logue GL
    Br J Haematol; 1972 Dec; 23(6):693-705. PubMed ID: 4630453
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanisms of immune lysis of red blood cells in vitro. I. Paroxysmal nocturnal hemoglobinuria cells.
    Logue GL; Rosse WF; Adams JP
    J Clin Invest; 1973 May; 52(5):1129-37. PubMed ID: 4700488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piperacillin-tazobactam drug-induced immune haemolysis in a case of paroxysmal nocturnal haemoglobinuria.
    McDonald L; Brodie R; Murphy K; Wright P; Webster R; Fitzgerald J
    Transfus Med; 2019 Apr; 29(2):138-140. PubMed ID: 30916843
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
    Rosenfeld SI; Jenkins DE; Leddy JP
    J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of complement in the sensitivity of the paroxysmal nocturnal haemoglobinuria red cell to immune lysis.
    Rosse WF; Dacie JV
    Bibl Haematol; 1965; 23():11-8. PubMed ID: 5885042
    [No Abstract]   [Full Text] [Related]  

  • 9. Lysis of erythrocytes by complement in the absence of antibody.
    Götze O; Müller-Eberhard HJ
    J Exp Med; 1970 Nov; 132(5):898-915. PubMed ID: 5470509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. II. The role of complement components in the increased sensitivity of PNH red cells to immune lysis.
    Rosse WF; Dacie JV
    J Clin Invest; 1966 May; 45(5):749-57. PubMed ID: 4956901
    [No Abstract]   [Full Text] [Related]  

  • 11. Complement lysis of human erythrocytes. III. Differing effectiveness of human and guinea pig C9 on normal and paroxysmal nocturnal hemoglobinuria cells.
    Rosenfeld SI; Packman CH; Jenkins DE; Countryman JK; Leddy JP
    J Immunol; 1980 Nov; 125(5):2063-8. PubMed ID: 6776186
    [No Abstract]   [Full Text] [Related]  

  • 12. Lysis of red blood cells in some haemolytic anaemias--the lytic effect of agkistrodon piscivorus venom in vitro.
    Brabec V; Kornalík F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(3):428-35. PubMed ID: 72030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-lymphocytes escape membrane defect in paroxysmal nocturnal haemoglobinuria.
    Cooper MR; Currie MS; Rustagi PK; Logue GL
    Br J Haematol; 1983 Oct; 55(2):263-71. PubMed ID: 6604541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombolytic therapy in paroxysmal nocturnal haemoglobinuria complicated by hepatic vein thrombosis.
    Frawley KJ; MacKechnie SG; Taylor KM
    Australas Radiol; 1993 Nov; 37(4):396-8. PubMed ID: 8257346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody.
    Rosse WF; Dacie JV
    J Clin Invest; 1966 May; 45(5):736-48. PubMed ID: 5935361
    [No Abstract]   [Full Text] [Related]  

  • 16. Study of in vitro lysis of paroxysmal nocturnal haemoglobinuria (PNH) and PNH-like red cells.
    Ferrone S; Marubini E; Mercuriali F; Sirchia G
    Br J Haematol; 1972 Jul; 23(1):5-12. PubMed ID: 5045962
    [No Abstract]   [Full Text] [Related]  

  • 17. The Budd-Chiari syndrome and paroxysmal nocturnal haemoglobinuria.
    Leibowitz AI; Hartmann RC
    Br J Haematol; 1981 May; 48(1):1-6. PubMed ID: 7018554
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful use of Arixtra in a patient with paroxysmal nocturnal hemoglobinuria, Budd-Chiari syndrome and heparin-induced thrombocytopenia.
    D'Amico EA; Villaça PR; Gualandro SF; Bassitt RP; Chamone DA
    J Thromb Haemost; 2003 Nov; 1(11):2452-3. PubMed ID: 14629485
    [No Abstract]   [Full Text] [Related]  

  • 19. Paroxysmal nocturnal hemoglobinuria and the complement system: recent insights and novel anticomplement strategies.
    Risitano AM
    Adv Exp Med Biol; 2013; 735():155-72. PubMed ID: 23402025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement lysis of human erythrocytes. Differeing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9.
    Packman CH; Rosenfeld SI; Jenkins DE; Thiem PA; Leddy JP
    J Clin Invest; 1979 Aug; 64(2):428-33. PubMed ID: 457861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.